Bio Marin Pharmaceutical Inc. Appoints Greg Friberg, M.D. As Evp, Chief Research & Development Officer and James Sabry, M.D., Ph.D. As Evp, Chief Business Officer
Bio Marin Pharmaceutical Inc. Appoints Greg Friberg, M.D. As Evp, Chief Research & Development Officer and James Sabry, M.D., Ph.D. As Evp, Chief Business Officer
08/21/24, 12:43 PM
Location
Industry
biotechnology
Position
chief business officer
chief research and development officer
BioMarin Pharmaceutical Inc. has announced the appointments of Greg Friberg, M.D. as Executive Vice President, Chief Research & Development Officer, succeeding Hank Fuchs, M.D., and James Sabry, M.D., Ph.D